Dow Down 3.39% Nasdaq Down 4.12%

Oramed Pharmaceuticals Inc. (ORMP)

-NasdaqCM
8.14 Down 0.01(0.12%) Jun 24, 4:00PM EDT
Prev Close:8.15
Open:8.03
Bid:6.40 x 700
Ask:9.75 x 100
1y Target Est:21.00
Beta:0.501912
Next Earnings Date:N/A
Day's Range:7.82 - 8.23
52wk Range:4.15 - 10.74
Volume:62,332
Avg Vol (3m):164,200
Market Cap:106.76M
P/E (ttm):N/A
EPS (ttm):-0.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ORMP

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):855.10
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Aug-16) :-0.67
Quarterly EPS Est (May-16) :-0.20
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback